EDWARD SANTIAGO: Open Payments
NPI 1770921058 · AZUSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 19 payments from 5 companies in 2025. Trend: 2023 $639 · 2024 $414 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 13 | $437 |
| Alkermes, Inc. | 3 | $162 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| ACADIA Pharmaceuticals Inc | 1 | $24 |
Products named: REXULTI, ABILIFY MAINTENA, ARISTADA, COBENFY, ABILIFY ASIMTUFII, AUSTEDO XR, NUPLAZID.
Industry payments across CA — which companies pay providers there.
